Evidence map›Paper›PMID 39187183›Full record

ArticleJournal of affective disorders2024

Relationships between serotonin 1A receptor DNA methylation, self-reported history of childhood abuse and gray matter volume in major depression.

Ariel R Goldenthal, Evan Lieberman, Mina M Rizk, R Todd Ogden, Harry Rubin-Falcone, Francesca Zanderigo, Yung-Yu Huang, Eli Min, Minlan Yuan, Matthew Milak and 5 more

Abstract read
In one paragraph

Article in Journal of affective disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ariel R GoldenthalDepartment of Psychiatry, Columbia University, New York, NY, United States of America.
Evan LiebermanMassachusetts General Hospital, Boston, MA, United States of America; McLean Hospital, Belmont, MA, United States of America.
Mina M RizkMolecular Imaging and Neuropathology Area, New York State Psychiatric Institute, New York, NY, United States of America; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, United States of America.
R Todd OgdenMolecular Imaging and Neuropathology Area, New York State Psychiatric Institute, New York, NY, United States of America; Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Harry Rubin-FalconeDepartment of Computer Science and Engineering, University of Michigan, Ann Arbor, MI, United States of America.
Francesca ZanderigoDepartment of Psychiatry, Columbia University, New York, NY, United States of America; Molecular Imaging and Neuropathology Area, New York State Psychiatric Institute, New York, NY, United States of America.
Yung-Yu HuangDepartment of Psychiatry, Columbia University, New York, NY, United States of America; Molecular Imaging and Neuropathology Area, New York State Psychiatric Institute, New York, NY, United States of America.
Eli MinDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, United States of America.
Minlan YuanMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.
Matthew MilakDepartment of Psychiatry, Columbia University, New York, NY, United States of America; Molecular Imaging and Neuropathology Area, New York State Psychiatric Institute, New York, NY, United States of America.
Gregory M SullivanTonix Pharmaceuticals Holding Corp., United States of America.
M Elizabeth SubletteDepartment of Psychiatry, Columbia University, New York, NY, United States of America; Molecular Imaging and Neuropathology Area, New York State Psychiatric Institute, New York, NY, United States of America.
Maria A OquendoDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
J John MannDepartment of Psychiatry, Columbia University, New York, NY, United States of America; Molecular Imaging and Neuropathology Area, New York State Psychiatric Institute, New York, NY, United States of America; Department of Radiology, Columbia University, New York, NY, United States of America.
Jeffrey M MillerDepartment of Psychiatry, Columbia University, New York, NY, United States of America; Molecular Imaging and Neuropathology Area, New York State Psychiatric Institute, New York, NY, United States of America. Electronic address: jeffrey.miller@nyspi.columbia.edu.

Funding

ZOLEDRONIC ACID IN PROSTATE CANCERM01RR000645 · NCRR · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI COLTEN, HARVEY R · 1985 to 2006
$27.0M
THE NEUROBIOLOGY OF SUICIDAL BEHAVIORP50MH062185 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MANN, JOSEPH JOHN · 2000 to 2009
$21.7M
Neurobiology of Depression and AntidepressantsR01MH040695 · NIMH · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI MANN, JOSEPH JOHN · 1986 to 2014
$7.1M
Biological Predictors of Response to AntidepressantsR01MH074813 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PARSEY, RAMIN V. · 2006 to 2010
$2.3M
The Antidepressant Action of Ketamine:Brain ChemistryR01MH093637 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MILAK, MATE ISTVAN · 2011 to 2014
$2.3M
Training the Next Generation of Psychiatrists-Scientists for Translational ResearchR25MH129256 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ANTONIA S NEW, Maria De Las Mercedes Perez Rodriguez · 2023 to 2026
$831k
NCRR NIH HHS M01 RR000645NIMH NIH HHS P50 MH062185NIMH NIH HHS R01 MH040695NIMH NIH HHS R01 MH074813NIMH NIH HHS R01 MH093637NIMH NIH HHS R25 MH129256
6 · The paper itself

Abstract

backgroundEarly life adversity is a risk factor for psychopathology and is associated with epigenetic alterations in the 5-HT

methodsPeripheral DNA methylation of 5-HT

resultsNo relationship was observed between DNA methylation and history of childhood abuse. We observed regional heterogeneity comparing -681 CpG site methylation and GMV (p = 0.014), with a positive relationship to GMV in orbitofrontal cortex (p = 0.035). Childhood abuse history was associated with higher GMV considering all ROIs simultaneously (p < 0.01). In whole-brain analyses, childhood abuse history was positively correlated with GMV in multiple clusters, including insula and orbitofrontal cortex (p LIMITATIONS: Small sample size, childhood trauma assessment instrument used, and assay of peripheral, rather than CNS, methylation.

conclusionsThese cross-sectional findings support hypotheses of 5-HT

Indexed as

DNA MethylationGray MatterMagnetic Resonance ImagingMajor Depressive DisorderReceptor, Serotonin, 5-HT1AAdultAdult Survivors of Child AbuseBrainCerebral CortexChildChild AbuseFemaleHumansMaleMiddle AgedPrefrontal CortexHTR1A protein, humanReceptor, Serotonin, 5-HT1AChildhood abuseGray matter volumeMajor depressive disorderMethylationVoxel based morphometry

Identifiers

PMID39187183
PMCPMC11558534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.